AXA S.A. - X4 PHARMACEUTICALS INC ownership

X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 60 filers reported holding X4 PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 2.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
AXA S.A. ownership history of X4 PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,431,173
-48.4%
3,147,865
-8.1%
0.01%
-45.5%
Q2 2023$6,644,477
+73.7%
3,424,988
-22.1%
0.02%
+69.2%
Q1 2023$3,824,927
-11.7%
4,396,468
+0.8%
0.01%
-18.8%
Q4 2022$4,331,110
-69.3%
4,361,641
-47.2%
0.02%
-42.9%
Q3 2022$14,112,247
+535.6%
8,252,920
+258.7%
0.03%
+600.0%
Q2 2022$2,220,201
-44.9%
2,300,934
-0.1%
0.00%
-33.3%
Q1 2022$4,029,845
+52.8%
2,302,680
+99.9%
0.01%
-14.3%
Q4 2021$2,638,000
-15.5%
1,151,819
+95.1%
0.01%
-22.2%
Q3 2021$3,123,000
-57.7%
590,269
-48.1%
0.01%
-18.2%
Q2 2021$7,390,000
+50.9%
1,136,832
+99.8%
0.01%
-26.7%
Q1 2021$4,898,000
+33.9%
568,847
-0.0%
0.02%
+36.4%
Q4 2020$3,659,000
-1.0%
568,995
+4.2%
0.01%
-15.4%
Q3 2020$3,697,000
-62.0%
546,078
-47.6%
0.01%
-31.6%
Q2 2020$9,722,000
-3.2%
1,043,068
+3.9%
0.02%
-24.0%
Q1 2020$10,044,0001,004,3260.02%
Other shareholders
X4 PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 12,202,510$10,6161.33%
Tri Locum Partners LP 3,878,484$3,374,2811.03%
Lynwood Capital Management Inc. 900,000$783,0000.71%
NEA Management Company, LLC 11,736,793$10,211,0100.71%
Parkman Healthcare Partners LLC 2,797,147$2,433,5180.53%
SCOGGIN MANAGEMENT LP 484,796$567,0250.33%
New Leaf Venture Partners, L.L.C. 335,000$291,4500.24%
Ghost Tree Capital, LLC 850,000$740,0000.22%
Perceptive Advisors 4,545,454$3,954,5450.12%
Orbimed Advisors 5,817,726$5,061,4220.10%
View complete list of X4 PHARMACEUTICALS INC shareholders